Physician profile
Dena Barrett
NPI 1790165827
$1,531.89
in general payments reported to CMS, 2019-2025
16 companies · $451 in 2025
The $451 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $125 · 2022: $397 · 2023: $469 · 2024: $90.21 · 2025: $451.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,010.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,009.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $346.08 | 2023-2025 | Airsupra, Breztri |
| Novo Nordisk INC | $283.42 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Inari Medical, INC. | $188.74 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Medtronic, INC. | $167.30 | 2022 | |
| Lilly USA, LLC | $112.57 | 2022-2023 | Mounjaro, Jardiance |
| Inspire Medical Systems, INC. | $84.05 | 2025 | Inspire |
| Shield Therapeutics INC | $62.26 | 2022-2023 | Accrufer |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $51.01 | 2022-2023 | Xifaxan, Trulance |
| Amarin Pharma, INC. | $47.04 | 2022 | |
| Abbvie INC. | $41.43 | 2023 | |
| Glaxosmithkline, LLC. | $40.97 | 2022-2023 | Trelegy Ellipta |
| Pfizer INC. | $33.28 | 2023 | |
| Janssen Pharmaceuticals, INC | $21.35 | 2023 | Xarelto |
| Azurity Pharmaceuticals, INC. | $18.05 | 2023 | Edarbyclor |
| Bausch Health US, LLC | $17.40 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $16.94 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dena Barrett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.